OptoIntel is a medical technology startup at the forefront of developing accessible and routine screening methods for Alzheimer’s disease, aiming to make such assessments as commonplace as blood pressure checks. Emphasizing the critical importance of early detection in improving patient outcomes, the company integrates advanced hyperspectral